Okada S - Search Results

1

Small-field radiotherapy in combination with concomitant chemotherapy for locally advanced pancreatic carcinoma.

Tokuuye K, Sumi M, Kagami Y, Murayama S, Ikeda H, Ikeda M, Okusaka T, Ueno H, Okada S. Tokuuye K, et al. Among authors: okada s. Radiother Oncol. 2003 Jun;67(3):327-30. doi: 10.1016/s0167-8140(03)00118-x. Radiother Oncol. 2003. PMID: 12865182

2

Phase I and pharmacokinetic study of 5-fluorouracil administered by 5-day continuous infusion in patients with hepatocellular carcinoma.

Ueno H, Okada S, Okusaka T, Ikeda M, Kuriyama H. Ueno H, et al. Among authors: okada s. Cancer Chemother Pharmacol. 2002 Feb;49(2):155-60. doi: 10.1007/s00280-001-0400-8. Epub 2001 Nov 28. Cancer Chemother Pharmacol. 2002. PMID: 11862430 Clinical Trial.

3

Phase II study of uracil-tegafur in patients with metastatic pancreatic cancer.

Ueno H, Okada S, Okusaka T, Ikeda M, Kuriyama H. Ueno H, et al. Among authors: okada s. Oncology. 2002;62(3):223-7. doi: 10.1159/000059569. Oncology. 2002. PMID: 12065869 Clinical Trial.

4

Transcatheter arterial embolization with zinostatin stimalamer for hepatocellular carcinoma.

Okusaka T, Okada S, Ueno H, Ikeda M, Iwata R, Furukawa H, Takayasu K, Moriyama N, Sato T, Sato K. Okusaka T, et al. Among authors: okada s. Oncology. 2002;62(3):228-33. doi: 10.1159/000059570. Oncology. 2002. PMID: 12065870 Clinical Trial.

5

Protracted 5-fluorouracil infusion with concurrent radiotherapy as a treatment for locally advanced pancreatic carcinoma.

Ishii H, Okada S, Tokuuye K, Nose H, Okusaka T, Yoshimori M, Nagahama H, Sumi M, Kagami Y, Ikeda H. Ishii H, et al. Among authors: okada s. Cancer. 1997 Apr 15;79(8):1516-20. Cancer. 1997. PMID: 9118032 Clinical Trial.

6

A case of pancreatic cancer achieving symptomatic improvement with systemic chemotherapy.

Kosakamoto H, Okada S, Ueno H, Okusaka T, Ikeda M, Tanaka N, Yoshimori M, Matsuno Y. Kosakamoto H, et al. Among authors: okada s. Hepatogastroenterology. 1999 Jul-Aug;46(28):2621-4. Hepatogastroenterology. 1999. PMID: 10522052

7

A phase II study of sequential methotrexate and 5-fluorouracil in metastatic pancreatic cancer.

Ikeda M, Okada S, Ueno H, Okusaka T, Tanaka N, Kuriyama H, Yoshimori M. Ikeda M, et al. Among authors: okada s. Hepatogastroenterology. 2000 May-Jun;47(33):862-5. Hepatogastroenterology. 2000. PMID: 10919048 Clinical Trial.

8

Radiotherapy for hepatocellular carcinoma.

Tokuuye K, Sumi M, Kagami Y, Murayama S, Kawashima M, Ikeda H, Ueno H, Okusaka T, Okada S. Tokuuye K, et al. Among authors: okada s. Strahlenther Onkol. 2000 Sep;176(9):406-10. doi: 10.1007/pl00002348. Strahlenther Onkol. 2000. PMID: 11050913

9

Prognostic factors in patients with metastatic pancreatic adenocarcinoma receiving systemic chemotherapy.

Ueno H, Okada S, Okusaka T, Ikeda M. Ueno H, et al. Among authors: okada s. Oncology. 2000 Nov;59(4):296-301. doi: 10.1159/000012186. Oncology. 2000. PMID: 11096341

10

Prognostic factors in patients with locally advanced pancreatic carcinoma receiving chemoradiotherapy.

Ikeda M, Okada S, Tokuuye K, Ueno H, Okusaka T. Ikeda M, et al. Among authors: okada s. Cancer. 2001 Feb 1;91(3):490-5. doi: 10.1002/1097-0142(20010201)91:3<490::aid-cncr1027>3.0.co;2-l. Cancer. 2001. PMID: 11169931

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

4,550 results

Search Page

Filters